NCT06102252View on ClinicalTrials.gov

Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 15, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions

Endometrial Carcinoma

Interventions

DRUG

Paclitaxel/epirubcin/carboplatin

adjuvant treatment in endometrial carcinoma

DRUG

Paclitaxel/carboplatin

Dose dense paclitaxel/carboplatin

Trial Locations (1)

Sohag

Sohag university Hospital, Sohag

All Listed Sponsors

lead

Sohag University

OTHER

NCT06102252 - Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma | Biotech Hunter | Biotech Hunter